(a) Adjusted mean (SE) change in HbA1c from baseline with
vildagliptin 50 mg once daily (n=78) or sitagliptin 25 mg once daily
(n=62), p=0.874. (b) Adjusted mean (SE) change in FPG from baseline
with vildagliptin 50 mg once daily (n=79) or sitagliptin 25 mg once daily
(n=62), p=0.185. (c) Percentage of patients achieving HbA1c ≤6.5% an